Expert Opinion on Investigational Drugs, Volume 28, Issue 1 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 28, Issue 1 (2019)

See all volumes and issues
Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Volume 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Drug Evaluation

Article
Atezolizumab for the treatment of triple-negative breast cancer
Anne-Sophie Heimes & Marcus Schmidt
Pages: 1-5
Published online: 01 Dec 2018
AbstractforAtezolizumab for the treatment of triple-negative breast cancer | Full Text | References | PDF (451.4 KB) | EPUB
  • 1782 Views
  • 57 CrossRef citations
  • 0Altmetric

Review

Article
Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma
I-Tao Huang, Bijay Dhungel, Ritu Shrestha, Kim R. Bridle, Darrell H. G. Crawford, Aparna Jayachandran & Jason C Steel
Pages: 7-18
Published online: 30 Nov 2018
AbstractforSpotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma | Full Text | References | PDF (1.1 MB) | EPUB
  • 391 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Therapeutic targets and early stage clinical trials for pulmonary fibrosis
Seidai Sato, Toyoshi Yanagihara & Martin R. J. Kolb
Pages: 19-28
Published online: 06 Dec 2018
AbstractforTherapeutic targets and early stage clinical trials for pulmonary fibrosis | Full Text | References | PDF (926.1 KB) | EPUB
  • 681 Views
  • 14 CrossRef citations
  • 0Altmetric
Review
HER2-targeted therapy: an emerging strategy in advanced colorectal cancer
Anna La Salvia, Victoria Lopez-Gomez & Rocio Garcia-Carbonero
Pages: 29-38
Published online: 09 Dec 2018
AbstractforHER2-targeted therapy: an emerging strategy in advanced colorectal cancer | Full Text | References | PDF (770.4 KB) | EPUB
  • 852 Views
  • 25 CrossRef citations
  • 0Altmetric
Review
Investigational therapies in phase II clinical trials for the treatment of soft tissue sarcoma
Juan Martin-Liberal, Ezequiel Pérez & Xavier García Del Muro
Pages: 39-50
Published online: 05 Dec 2018
AbstractforInvestigational therapies in phase II clinical trials for the treatment of soft tissue sarcoma | Full Text | References | PDF (902.1 KB) | EPUB
  • 685 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
New drugs in preclinical and early stage clinical development in the treatment of heart failure
Juan Tamargo, Ricardo Caballero & Eva Delpón
Pages: 51-71
Published online: 07 Dec 2018
AbstractforNew drugs in preclinical and early stage clinical development in the treatment of heart failure | Full Text | References | PDF (1.5 MB) | EPUB
  • 537 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives
Giancarlo Marone, Maria Rosaria Galdiero, Antonio Pecoraro, Valentina Pucino, Gjada Criscuolo, Maria Triassi & Gilda Varricchi
Pages: 73-84
Published online: 07 Dec 2018
AbstractforProstaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives | Full Text | References | PDF (1 MB) | EPUB
  • 853 Views
  • 46 CrossRef citations
  • 0Altmetric
Article
The Jakinibs in systemic lupus erythematosus: progress and prospects
Chi Chiu Mok
Pages: 85-92
Published online: 26 Nov 2018
AbstractforThe Jakinibs in systemic lupus erythematosus: progress and prospects | Full Text | References | PDF (900.9 KB) | EPUB
  • 1504 Views
  • 53 CrossRef citations
  • 0Altmetric

Editorial

Article
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
Antoni Camins, Miren Ettcheto, Oriol Busquets, Patricia R. Manzine, Rubén Dario Castro-Torres, Carlos Beas-Zarate, Ester Verdaguer, Francesc X. Sureda, Monica Bulló, Jordi Olloquequi, Carme Auladell & Jaume Folch
Pages: 93-97
Published online: 01 Dec 2018
First Page PreviewforTriple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease | Full Text | References | PDF (545.8 KB) | EPUB
  • 472 Views
  • 5 CrossRef citations
  • 0Altmetric

Explore articles